Humatech Stock Current Asset
| HUMT Stock | USD 0.0001 0.00 0.00% |
Humatech fundamentals help investors to digest information that contributes to Humatech's financial success or failures. It also enables traders to predict the movement of Humatech Stock. The fundamental analysis module provides a way to measure Humatech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Humatech stock.
Other Current Assets is likely to gain to about 28.8 K in 2024, whereas Total Current Assets are likely to drop slightly above 120 K in 2024. Humatech | Current Asset |
Humatech Company Current Asset Analysis
Humatech's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Humatech Current Asset | 250 K |
Most of Humatech's fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Humatech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Humatech Current Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Humatech is extremely important. It helps to project a fair market value of Humatech Stock properly, considering its historical fundamentals such as Current Asset. Since Humatech's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Humatech's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Humatech's interrelated accounts and indicators.
Click cells to compare fundamentals
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
Humatech Total Assets
Total Assets |
|
In accordance with the recently published financial statements, Humatech has a Current Asset of 250 K. This is 100.0% lower than that of the Chemicals sector and 99.98% lower than that of the Materials industry. The current asset for all United States stocks is 100.0% higher than that of the company.
Humatech Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Humatech's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Humatech could also be used in its relative valuation, which is a method of valuing Humatech by comparing valuation metrics of similar companies.Humatech is currently under evaluation in current asset category among its peers.
Humatech Fundamentals
| Return On Asset | -1.01 | ||||
| Profit Margin | (0.46) % | ||||
| Operating Margin | (0.38) % | ||||
| Current Valuation | 9.5 K | ||||
| Shares Outstanding | 95 M | ||||
| Price To Earning | (0.24) X | ||||
| Price To Sales | 0.01 X | ||||
| Revenue | 1.57 M | ||||
| Gross Profit | 499.39 K | ||||
| EBITDA | (499.67 K) | ||||
| Net Income | (700.99 K) | ||||
| Cash And Equivalents | 3.36 K | ||||
| Total Debt | 285.33 K | ||||
| Current Ratio | 0.11 X | ||||
| Book Value Per Share | (0.04) X | ||||
| Cash Flow From Operations | 4.22 K | ||||
| Beta | -9.21 | ||||
| Market Capitalization | 9.5 K | ||||
| Total Asset | 354.97 K | ||||
| Retained Earnings | (11.61 M) | ||||
| Working Capital | (1.22 M) | ||||
| Current Asset | 250 K | ||||
| Current Liabilities | 1.47 M | ||||
| Net Asset | 354.97 K |
About Humatech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Humatech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Humatech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Humatech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Humatech Stock Analysis
When running Humatech's price analysis, check to measure Humatech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humatech is operating at the current time. Most of Humatech's value examination focuses on studying past and present price action to predict the probability of Humatech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humatech's price. Additionally, you may evaluate how the addition of Humatech to your portfolios can decrease your overall portfolio volatility.